Funders

Material and financial support for the research conducted at the HIV Cure Center comes from a broad base of public and private sources.

UNC and ViiV Healthcare created a jointly owned company, Qura Therapeutics, that provided financial and material support to the HIV Cure Center, including the creation of a joint team of scientists based at the Chapel Hill campus working together on several exciting areas of research to cure HIV.

Principal Investigators and staff of the UNC HIV Cure Center are supported by federal funding sources and foundation grants. In July 2015, researchers at the University of North Carolina at Chapel Hill received $28 million over five years to continue their innovative “kick and kill” strategy for eradicating HIV. The National Institutes of Health (NIH) selected the Collaboratory of AIDS Researchers for Eradication (CARE), which is based at UNC, for refunding after a competitive application process in 2021.

Additional diversification and expansion of the funding base for the UNC HIV Cure Center is actively and continuously being pursued.